Thesis Abstract

Abstract
The field of cancer therapy is constantly evolving, with researchers striving to develop more effective treatment modalities that can specifically target cancer cells while minimizing harm to healthy tissues. In this regard, the development of novel drug delivery systems tailored for targeted cancer therapy has emerged as a promising approach. This thesis presents a comprehensive investigation into the design, development, and evaluation of a novel drug delivery system for targeted cancer therapy. The study begins with an introduction that outlines the background and significance of the research, followed by a detailed discussion of the problem statement, objectives, limitations, scope, and significance of the study, as well as the structure of the thesis and definitions of key terms. A thorough literature review is conducted to provide a comprehensive overview of existing drug delivery systems, their limitations, and the potential for improvement through targeted approaches. The research methodology chapter outlines the experimental design, materials, and methods employed in the development and evaluation of the novel drug delivery system. Key aspects such as drug loading efficiency, release kinetics, and in vitro and in vivo testing protocols are discussed in detail. The findings chapter presents a comprehensive analysis of the experimental results, including drug release profiles, cellular uptake studies, and efficacy assessments in animal models of cancer. The discussion of findings delves into the implications of the results, comparing them to existing literature and highlighting the significance of the novel drug delivery system in the context of targeted cancer therapy. Finally, the conclusion and summary chapter provides a comprehensive overview of the study, highlighting key findings, implications for future research, and potential clinical applications of the developed drug delivery system. Overall, this thesis contributes to the field of cancer therapy by presenting a novel drug delivery system that shows promise for targeted cancer treatment. The research findings underscore the importance of targeted approaches in enhancing the efficacy and safety of cancer therapy, paving the way for further advancements in the field.

Thesis Overview

The project titled "Development of a Novel Drug Delivery System for Targeted Cancer Therapy" aims to address the current challenges in cancer treatment by focusing on the development of a specialized drug delivery system. Cancer remains a leading cause of mortality worldwide, and the need for more effective and targeted therapies is crucial. Conventional cancer treatments, such as chemotherapy, often have significant side effects due to their non-specific nature, impacting healthy cells along with cancerous ones. The proposed research seeks to develop a novel drug delivery system that can target cancer cells more specifically, thus enhancing treatment efficacy while minimizing adverse effects. By utilizing advanced technologies and techniques, the project aims to design a delivery system that can deliver therapeutic agents directly to cancer cells, increasing the concentration of the drug at the target site while reducing exposure to healthy tissues. The research will involve a multidisciplinary approach, incorporating aspects of pharmaceutical sciences, nanotechnology, and bioengineering. Through an in-depth investigation of existing drug delivery systems and cutting-edge research in the field, the project will identify key components necessary for an effective targeted drug delivery system. The development process will involve formulation optimization, testing for biocompatibility and efficacy, and validation through in vitro and in vivo studies. The ultimate goal of this research is to contribute to the advancement of cancer therapy by providing a more precise and efficient drug delivery system. By improving the targeting of therapeutic agents to cancer cells, this novel approach has the potential to enhance treatment outcomes, reduce side effects, and improve patient quality of life. The findings from this study could have significant implications for the future of cancer treatment and pave the way for personalized and targeted therapies in oncology.